SIGA Technologies Inc. (SIGA) Financial Statements (2023 and earlier)

Company Profile

Business Address 31 EAST 62ND STREET
NEW YORK, NY 10065
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments103,139117,89065,249100,65319,85828,702112,711
Cash and cash equivalents103,139117,89065,249100,65319,85828,702112,711
Restricted cash and investments  95,73811,45210,70110,139 
Receivables83,6503,3404,1681,9591,8023,1543,677
Inventory, net of allowances, customer advances and progress billings19,51020,2669,6532,9082,98326,21012,447
Inventory19,51020,2669,6532,9082,98326,21012,447
Other undisclosed current assets2,4532,1125,2344,3182,020954624
Total current assets:208,753143,608180,042121,29037,36469,159129,459
Noncurrent Assets
Property, plant and equipment2,3662,1042,618171139299450
Intangible assets, net (including goodwill)898898898898898898898
Goodwill898898898898898898898
Restricted cash and investments 2,544 68,2926,54217,333 
Deferred costs    96,59272,64952,936
Deferred income tax assets2,423  
Other noncurrent assets2876778571,0597026421,990
Deferred tax assets, net11,7332,432  
Other undisclosed noncurrent assets  14,151    
Total noncurrent assets:5,9736,22318,52482,154107,30691,82356,274
TOTAL ASSETS:214,727149,831198,566203,444144,670160,982185,733
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30,48810,48411,69111,3376,8107,1027,333
Accounts payable2,0281,2783,0541,6881,3292,5173,944
Accrued liabilities9,2539,2058,6379,6495,4824,5853,389
Taxes payable19,207      
Debt  80,045    
Other undisclosed current liabilities     6,727 
Total current liabilities:30,48810,48491,73611,3376,81013,8297,333
Noncurrent Liabilities
Liabilities, other than long-term debt    377,641367,770255,524
Deferred revenue and credits377,641367,484255,258
Deferred tax liabilities, net  286266
Other undisclosed noncurrent liabilities9,9249,5559,04789,19283,35766,801207,304
Total noncurrent liabilities:9,9249,5559,04789,192460,998434,571462,828
Total liabilities:40,41220,038100,782100,529467,809448,400470,161
Stockholders' equity
Stockholders' equity attributable to parent174,314129,79397,784102,915(323,138)(287,418)(284,429)
Common stock7888885
Additional paid in capital226,070224,978220,808218,698214,230213,714177,008
Accumulated deficit(51,763)(95,193)(123,032)(115,791)(537,376)(501,140)(461,442)
Total stockholders' equity:174,314129,79397,784102,915(323,138)(287,418)(284,429)
TOTAL LIABILITIES AND EQUITY:214,727149,831198,566203,444144,670160,982185,733

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues133,670124,95926,742477,054   
Cost of revenue(17,312)(15,517)(1,783)(95,269)(536)  
Cost of goods and services sold(16,602)(14,797)  (536)  
Gross profit:116,358109,44324,959381,785(536)  
Operating expenses(27,266)(24,942)(29,064)(121,954)(31,118)(46,003)(39,129)
Other undisclosed operating income  1,78395,26912,80514,9888,176
Operating income (loss):89,09384,501(2,322)355,099(18,849)(31,015)(30,953)
Nonoperating income1015322,82278,9411710242
Interest and debt expense (7,998)(15,770)(15,478)(14,758)(2,396)(267)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes (3,526)5,091(6,923)(4,739)(6,376)(7,812)
Income (loss) from continuing operations before equity method investments, income taxes:89,19473,509(10,178)411,640(38,329)(39,684)(38,989)
Other undisclosed income from continuing operations before income taxes118      
Income (loss) from continuing operations before income taxes:89,31273,509(10,178)411,640(38,329)(39,684)(38,989)
Income tax expense (benefit)(19,861)(17,167)2,93710,1682,094(14)(462)
Net income (loss) available to common stockholders, diluted:69,45156,342(7,241)421,808(36,235)(39,698)(39,451)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):69,45156,342(7,241)421,808(36,235)(39,698)(39,451)
Comprehensive income (loss), net of tax, attributable to parent:69,45156,342(7,241)421,808(36,235)(39,698)(39,451)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: